Skip to content
All programs presented are currently in research and development. Potential indications and applications reflect development objectives and do not represent established efficacy, safety or regulatory approval.

Leadership

Leadership

Experienced leaders. One shared commitment to science, patients and building ObNowa.

Portrait of Kenton Abel

Kenton Abel, PhD, JD

Chairman & CEO

Key areas

Strategy · Science & Innovation · Portfolio · Governance

Portrait of Maksymilian Świniarski

Maksymilian Świniarski

President

Key areas

Business Development · Partnerships · Fundraising · Commercial Strategy

Portrait of Marta Rzeszotarska

Marta Rzeszotarska

Chief of Staff

Key areas

Operations · Coordination · Governance Support · Execution

Governance

Board of Directors

Portrait of Dan Radecki

Dan Radecki, PhD, MA

Key expertise

Neurotoxin Science · Drug Development · Translational R&D

Portrait of Eric Chojnicki

Eric Chojnicki, PhD, MBA

Key expertise

Biologics · CMC · Product Development

Portrait of Dennis Fluet

Dennis Fluet

Key expertise

Healthcare Strategy · Investor Relations · Commercialisation · Partnerships

Portrait of Marek Wasiluk

Marek Wasiluk, DMD, MSc, MBA

Key expertise

Aesthetic Medicine · Clinical Research · Medical Expertise

Work with us

A question for ourleadership team?

Contact us directly.

ObNowa Pharma

ObNowa Pharma is a global pharmaceutical development company headquartered in Warsaw, Poland. We combine science, pharmaceutical innovation and rigorous clinical development, focusing on solutions that matter to patients and physicians. Our portfolio spans two complementary areas: hair growth and neurotoxin-based medical aesthetics.

Warsaw · Poland · EU

Enquiries

Development status

All programs presented are currently in research and development. Potential indications and applications reflect development objectives and do not represent established efficacy, safety or regulatory approval.

© 2026 ObNowa Pharma Prosta Spółka Akcyjna. All rights reserved.